Cambridge Heart
Tewksbury, US
Biotech
Founders & leadership
JF
John F. McGuireNamed on SEC filing
RD
Roderick de GreefNamed on SEC filing
PM
Paul McCormickNamed on SEC filing
AH
Ali Haghighi-Mood, Ph.D.Named on SEC filing
JW
Jeffrey WigginsNamed on SEC filing
VL
Vincenzo LiCausiNamed on SEC filing
Reported raises · per SEC filings
Form D private placements$2.9M disclosed across 1 round · 2012
▶$2.9MraisedMar 2012 · 20 investors · BiotechnologyRule 506(b)
▶$2.9MraisedMar 2012 · 20 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- John F. McGuireDirector
- Roderick de GreefExecutive Officer, Director
- Paul McCormickDirector
- Ali Haghighi-Mood, Ph.D.Executive Officer, Director
- Jeffrey WigginsDirector
- Vincenzo LiCausiExecutive Officer
- Offering amount
- $4M
- Amount sold
- $2.9M
- Minimum investment
- $25K
- Sales commissions
- $280.8K
- Placement agents
- Dawson James Securities, Inc.
- First sale
- Jan 2012
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Frequently asked questions
- How much funding has Cambridge Heart raised?
- Cambridge Heart has disclosed $2.9M raised across 1 round.
- Where is Cambridge Heart headquartered?
- Cambridge Heart is headquartered in Tewksbury, US.